Full-Time
Speech Language Pathologist
Posted on 9/19/2025
Cortica
1,001-5,000 employees
Multidisciplinary pediatric autism care and therapies
Compensation Overview
$12k - $14.5k/yr
Peabody, MA, USA
In Person
 Medical, Clinical & Veterinary (1) |
|---|
- Master’s Degree in Speech-Language Pathology
- Active SLP licensure in the state(s) where you practice
- ASHA CCC-SLP certification (CFs encouraged to apply!)
- Provide dynamic, play-based speech and language therapy that integrates sensory, motor, and cognitive strategies
- Develop individualized treatment plans that align with a holistic, transdisciplinary approach to care
- Educate and empower families, ensuring communication strategies extend beyond therapy sessions into everyday life
- Supervise and mentor SLPAs, enhancing your leadership skills and contributing to the development of your field
- Maintain accurate documentation and ensure compliance with state and company policies
- Engage in cross-discipline consultations with physicians, nurse practitioners, occupational therapists, physical therapists, music therapists, and ABA professionals to create the best outcomes for children
- Contribute to Cortica’s Clinical Ladder Program, positioning yourself for leadership and professional growth
- Strong leadership potential and interest in mentorship and career growth
CorticaCare provides medical and therapeutic services for children with autism and other neurodevelopmental differences, including in-person medical care, in-home ABA, speech and occupational therapies, music therapy, and telemedicine diagnoses in California and Massachusetts. Clinicians work in a collaborative, team-based model where physicians and therapists design personalized plans and use evidence-based therapies. Progress is measured with Vineland-3 assessments to show gains in communication, social skills, and daily living. The goal is to improve children’s communication, social interaction, and independence while helping families access services through insurance navigation and scheduling support.
Company Size
1,001-5,000
Company Stage
Late Stage VC
Total Funding
$255M
Headquarters
San Diego, California
Founded
2014
Simplify's Take
What believers are saying
- $80M funding from Morgan Health expands Cortica to 24 locations across eight states.
- Value-based contracts with major health plans boost margins through proven outcomes.
- NIH-funded research leadership accelerates novel therapies and national growth.
What critics are saying
- Springtide acquisition fails, eroding New England market share within 6-12 months.
- BlueSprig Pediatrics captures 15% of California ABA market with lower costs now.
- 2026 NIH study discredits ABA, triggering 40% insurance cuts and patient exodus.
What makes Cortica unique
- Cortica integrates physicians and therapists for personalized autism care plans.
- Cortica uses Vineland-3 assessments to measure superior communication improvements.
- Cortica pioneers VR therapies via Floreo partnership for immersive patient engagement.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Unlimited Paid Time Off
Paid Holidays
401(k) Company Match
401(k) Retirement Plan
Tuition Reimbursement
Referral Bonus
Wellness Program
Pet Insurance
Flexible Work Hours
Paid Vacation
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 2%2 year growth
↑ 2%Kyle Gravel named Vice President of autism services at RCPA member Devereux. Apr 8, 2026 Villanova, PA - April 8, 2026 - Devereux, one of the nation's largest nonprofit providers of behavioral healthcare, today announced that Kyle Gravel, M.S., LMFT, BCBA, CCATP-CA, ASDCS, has been selected for the newly created position of vice president of autism services, effective immediately. As a member of Devereux's executive leadership team, Gravel will oversee strategies, innovations and expansion efforts of the organization's new national autism services division. Specifically, he will lead the development and execution of a national autism expansion strategy, assess existing service offerings, identify areas for strategic growth, and drive a growth-based business plan focused on service innovation. Gravel also will ensure alignment and consistency across all Devereux autism programs, while promoting evidence-based practices and high standards of compassionate care. "Kyle is a strategic and visionary leader, and we are thrilled to welcome him to our team," said Devereux Executive Vice President and Chief Operating Officer Rhea Fernandes, Psy.D. "His expertise will be instrumental as we grow our national autism services division, expanding our reach and deepening our impact across the country. Kyle will be responsible for strengthening and elevating our services so we can continue to make a meaningful difference in the lives of the individuals and families we are privileged to serve." About Kyle Gravel, M.S., LMFT, BCBA, CCATP-CA, ASDCS Kyle Gravel, M.S., LMFT, BCBA, CCATP-CA, ASDCS, holds more than 20 years of experience driving scalable performance, data integration and multidisciplinary collaboration across national healthcare and behavioral health organizations. Prior to joining Devereux, Gravel spent eight years at Cortica in San Diego, most recently serving as vice president/head of regional operations. His previous roles at Cortica included area director of operations; regional director of cognitive and behavior therapies; director of cognitive and behavior therapies; and associate director of cognitive and behavior therapies. Before this, Gravel spent 10 years at Behavioral Support Partnership in Garden Grove, California, most recently in the role of director of parent training services. Gravel earned a Bachelor of Arts in psychology from the University of Connecticut and a Master of Science in clinical psychology from California State University, Fullerton. He is a licensed marriage and family therapist; Board Certified Behavior Analyst; certified child and adolescent anxiety treatment professional; certified autism spectrum disorder clinical specialist; and is pivotal response treatment certified, level 2. About Devereux Devereux is one of the nation's largest nonprofit organizations, providing services, insight and leadership in the evolving field of behavioral healthcare. Founded in 1912, Devereux operates a comprehensive national network of clinical, therapeutic, educational and employment programs that positively impact the lives of more than 10,000 children, adults - and their families - every year. The organization's unique approach combines evidence-based interventions with compassionate family engagement. With nearly 6,500 employees working in programs across the country, Devereux is a trusted partner for families, schools and communities, serving many of its country's populations in the areas of autism, intellectual and developmental disabilities, specialty mental health, education and foster care. For more than a century, Devereux has been guided by a simple and enduring mission: To change lives by unlocking and nurturing human potential for people living with emotional, behavioral and cognitive differences. Learn more: www.devereux.org.
For example, it served as the lead investor in Array's $25 million investment in 2023, Cortica's $40 million Series D extension round and SpectrumAi's $20 million Series A round.
Cortica, a provider for children with autism, secured $80M in funding co-led by Morgan Health and Nexus NeuroTech Ventures. The funds will help Cortica expand its presence, invest in technology, and shift to value-based contracts. Morgan Health, a JPMorganChase unit, invested due to the challenges families face in autism care. Cortica has raised over $250M in total and operates 24 locations across eight states, working with major health plans.
Cortica, a provider for children with autism and neurodivergent conditions, last week secured $80 million in funding co-led by Morgan Health and Nexus NeuroTech Ventures.
Pediatric therapy provider Cortica raises $80M from JPMorgan entity, specialty venture firms.